ALNXT Fundamental Analysis - NEXTEDIA

Fundamental Rating

Overall ALNXT gets a fundamental rating of 5 out of 10. We evaluated ALNXT against 76 industry peers in the IT Services industry. The financial health of ALNXT is average, but there are quite some concerns on its profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ALNXT.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALNXT had positive earnings in the past year.

In the past year ALNXT had a positive cash flow from operations.

In the past 5 years ALNXT has always been profitable.

ALNXT had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of ALNXT (2.83%) is worse than 60.53% of its industry peers.

Looking at the Return On Equity, with a value of 4.93%, ALNXT is doing worse than 63.16% of the companies in the same industry.

ALNXT has a Return On Invested Capital (6.30%) which is in line with its industry peers.

ALNXT had an Average Return On Invested Capital over the past 3 years of 6.20%. This is significantly below the industry average of 25.87%.

The 3 year average ROIC (6.20%) for ALNXT is below the current ROIC(6.30%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	2.83%
ROE	4.93%
ROIC	6.3%

ROA(3y)2.64%

ROA(5y)3.08%

ROE(3y)5.31%

ROE(5y)6.42%

ROIC(3y)6.2%

ROIC(5y)6.1%

1.3 Margins

Looking at the Profit Margin, with a value of 2.50%, ALNXT is in line with its industry, outperforming 43.42% of the companies in the same industry.

ALNXT's Profit Margin has declined in the last couple of years.

Looking at the Operating Margin, with a value of 5.15%, ALNXT is in line with its industry, outperforming 47.37% of the companies in the same industry.

In the last couple of years the Operating Margin of ALNXT has declined.

ALNXT has a worse Gross Margin (54.19%) than 60.53% of its industry peers.

In the last couple of years the Gross Margin of ALNXT has declined.

		Industry Rank	Sector Rank
OM	5.15%
PM (TTM)	2.5%
GM	54.19%

OM growth 3Y-10.16%

OM growth 5Y-2.26%

PM growth 3Y-8.02%

PM growth 5Y-2.63%

GM growth 3Y-8.46%

GM growth 5Y-11.02%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALNXT is destroying value.

The number of shares outstanding for ALNXT remains at a similar level compared to 1 year ago.

Compared to 5 years ago, ALNXT has more shares outstanding

ALNXT has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.15 indicates that ALNXT is not a great score, but indicates only limited risk for bankruptcy at the moment.

With a Altman-Z score value of 2.15, ALNXT is not doing good in the industry: 60.53% of the companies in the same industry are doing better.

ALNXT has a debt to FCF ratio of 3.10. This is a good value and a sign of high solvency as ALNXT would need 3.10 years to pay back of all of its debts.

ALNXT has a Debt to FCF ratio (3.10) which is comparable to the rest of the industry.

ALNXT has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.

ALNXT has a Debt to Equity ratio of 0.12. This is amongst the best in the industry. ALNXT outperforms 80.26% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.12
Debt/FCF	3.1
Altman-Z	2.15

ROIC/WACC0.92

WACC6.81%

2.3 Liquidity

A Current Ratio of 1.25 indicates that ALNXT should not have too much problems paying its short term obligations.

ALNXT's Current ratio of 1.25 is in line compared to the rest of the industry. ALNXT outperforms 51.32% of its industry peers.

ALNXT has a Quick Ratio of 1.25. This is a normal value and indicates that ALNXT is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.25, ALNXT is in line with its industry, outperforming 59.21% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.25
Quick Ratio	1.25

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALNXT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.13%, which is quite impressive.

ALNXT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.66% yearly.

Looking at the last year, ALNXT shows a decrease in Revenue. The Revenue has decreased by -2.25% in the last year.

Measured over the past years, ALNXT shows a very strong growth in Revenue. The Revenue has been growing by 21.48% on average per year.

EPS 1Y (TTM)48.13%

EPS 3Y-3.66%

EPS 5Y3.66%

EPS Q2Q%4.76%

Revenue 1Y (TTM)-2.25%

Revenue growth 3Y8.74%

Revenue growth 5Y21.48%

Sales Q2Q%-8.17%

3.2 Future

ALNXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.47% yearly.

ALNXT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.18% yearly.

EPS Next Y20.64%

EPS Next 2Y9.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year13.87%

Revenue Next 2Y8.18%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.80, the valuation of ALNXT can be described as very reasonable.

93.42% of the companies in the same industry are more expensive than ALNXT, based on the Price/Earnings ratio.

ALNXT is valuated cheaply when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.

A Price/Forward Earnings ratio of 4.66 indicates a rather cheap valuation of ALNXT.

Based on the Price/Forward Earnings ratio, ALNXT is valued cheaply inside the industry as 94.74% of the companies are valued more expensively.

ALNXT is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.98, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	10.8
Fwd PE	4.66

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALNXT is valued a bit cheaper than the industry average as 76.32% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	9.23
EV/EBITDA	N/A

4.3 Compensation for Growth

ALNXT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)0.52

PEG (5Y)2.95

EPS Next 2Y9.47%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALNXT!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

NEXTEDIA

EPA:ALNXT (1/12/2026, 7:00:00 PM)

0.432

+0.01 (+1.65%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustryIT Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners17.68%

Ins Owner ChangeN/A

Market Cap16.85M

Revenue(TTM)62.04M

Net Income(TTM)1.55M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	10.8
Fwd PE	4.66
P/S	0.27
P/FCF	9.23
P/OCF	8.82
P/B	0.54
P/tB	14.54
EV/EBITDA	N/A

EPS(TTM)0.04

EY9.26%

EPS(NY)0.09

Fwd EY21.46%

FCF(TTM)0.05

FCFY10.84%

OCF(TTM)0.05

OCFY11.34%

SpS1.59

BVpS0.81

TBVpS0.03

PEG (NY)0.52

PEG (5Y)2.95

Graham Number0.85

Profitability

		Industry Rank	Sector Rank
ROA	2.83%
ROE	4.93%
ROCE	8.85%
ROIC	6.3%
ROICexc	7.81%
ROICexgc	N/A
OM	5.15%
PM (TTM)	2.5%
GM	54.19%
FCFM	2.94%

ROA(3y)2.64%

ROA(5y)3.08%

ROE(3y)5.31%

ROE(5y)6.42%

ROIC(3y)6.2%

ROIC(5y)6.1%

ROICexc(3y)8.02%

ROICexc(5y)8.4%

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)8.71%

ROCE(5y)8.58%

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3Y-9.69%

ROICexc growth 5Y-0.48%

OM growth 3Y-10.16%

OM growth 5Y-2.26%

PM growth 3Y-8.02%

PM growth 5Y-2.63%

GM growth 3Y-8.46%

GM growth 5Y-11.02%

F-Score7

Asset Turnover1.13

Health

		Industry Rank	Sector Rank
Debt/Equity	0.12
Debt/FCF	3.1
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	0.14%
Interest Coverage	250
Cash Conversion	N/A
Profit Quality	117.82%
Current Ratio	1.25
Quick Ratio	1.25
Altman-Z	2.15

F-Score7

WACC6.81%

ROIC/WACC0.92

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)0.47%

Cap/Sales(5y)0.35%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)48.13%

EPS 3Y-3.66%

EPS 5Y3.66%

EPS Q2Q%4.76%

EPS Next Y20.64%

EPS Next 2Y9.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-2.25%

Revenue growth 3Y8.74%

Revenue growth 5Y21.48%

Sales Q2Q%-8.17%

Revenue Next Year13.87%

Revenue Next 2Y8.18%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y5.19%

EBIT growth 3Y-2.31%

EBIT growth 5Y18.73%

EBIT Next Year22.44%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-22.15%

FCF growth 3Y-11.08%

FCF growth 5YN/A

OCF growth 1Y-33.49%

OCF growth 3Y-10.82%

OCF growth 5YN/A

NEXTEDIA / ALNXT.PA FAQ

Can you provide the ChartMill fundamental rating for NEXTEDIA?

ChartMill assigns a fundamental rating of 5 / 10 to ALNXT.PA.

What is the valuation status of NEXTEDIA (ALNXT.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to NEXTEDIA (ALNXT.PA). This can be considered as Undervalued.

What is the profitability of ALNXT stock?

NEXTEDIA (ALNXT.PA) has a profitability rating of 3 / 10.

How financially healthy is NEXTEDIA?

The financial health rating of NEXTEDIA (ALNXT.PA) is 5 / 10.

NEXTEDIA (ALNXT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

NEXTEDIA / ALNXT.PA FAQ

Can you provide the ChartMill fundamental rating for NEXTEDIA?

What is the valuation status of NEXTEDIA (ALNXT.PA) stock?

What is the profitability of ALNXT stock?

How financially healthy is NEXTEDIA?